Dr. Meggan C. MacKay, MD

Dr. MacKay practices at BronxCare Ambulatory Care Network in Bronx, New York.

Dr. MacKay's NPI, 1164542197, was assigned on March 31, 2007. Dr. MacKay graduated from New York Medical College in 1991. Dr. MacKay holds New York license 196738.

Dr. MacKay's primary practice is BronxCare Ambulatory Care Network, at 1650 Grand Concourse FL 14, Bronx, NY 10457 in Bronx County. The practice phone is (718) 518-5000.

Dr. MacKay's primary practice is BronxCare Ambulatory Care Network in Bronx, New York. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. MacKay to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. MacKay practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. MacKay's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. MacKay is licensed in New York.

Across all payers, Dmand AI patient panel data puts Dr. MacKay's median patient age at 49, with 86% women.

In 2024, Dr. MacKay wrote 746 Medicare Part D claims for 48 patients. 90% of them were for generic drugs. CMS names the drug for 591 of them, across 21 drugs with 11 or more claims each, at $234,155 in total drug cost. In 2023, CMS named 600 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. MacKay for performance year 2024, reported through an alternative payment model (APM). Dr. MacKay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 69 papers to Dr. MacKay, published from 2011 to 2025. 2019 was the busiest year, with 12. The most frequent topics are Lupus Erythematosus, Systemic, Autoantibodies and Antibodies, Antinuclear. Dr. MacKay has published most often in Arthritis Rheumatol. Dr. MacKay's most frequent co-authors are Cynthia B. Aranow, MD, Daniel J. Wallace, MD and Kenneth Carekin Kalunian, MD.

Dmand AI links Dr. MacKay to 9 clinical trials, 5 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Pemphigus. Northwell Health sponsors the most, 3. Open Payments lists research payments to Dr. MacKay that name 2 trials.

CMS Open Payments shows 14 general payments to Dr. MacKay from 6 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 42% of the total. Bristol-Myers Squibb Company paid the most, $2,925. It also lists 6 research payments totaling $25,428 from 2016 to 2022, naming 2 clinical trials.

Dr. MacKay graduated from New York Medical College in 1991.